Preoperative Study With Trastuzumab, Pertuzumab and Letrozole in Patients With Breast Cancer Sensitive to Hormonal Therapy

Condition:   Endocrine Sensitive HER2+/HR+ Breast CancerIntervention:   Drug: PertuzumabSponsors:   Istituto Oncologico Veneto IRCCS;   AS.T.R.O. Association for Translational Research in OncologyRecruiting - verified April 2015

Source: ClinicalTrials.gov - March 5, 2015 Category: Research Source Type: clinical trials